"Sequential Volumetric Modulated Arc Therapy (VMAT) Boost in Hy- brid Plan With Tangential Beams for Whole Breast Treatment: a Do- simetric Study "

Author:

Piras Antonio, ,Boldrini Luca,D'Aviero Andrea,Sanfratello Antonella,Menna Sebastiano,Massaccesi Mariangela,Spada Massimiliano,Pernice Gianfranco,Angileri Tommaso,Daidone Antonino, , , , , , , , ,

Abstract

"Purpose: Whole breast radiation therapy (WBRT) with a boost to the tumor bed following con-servative primary surgery in women with breast cancer (BC) plays a central role in reducing local recurrences and mortality. Volumetric modulated arc therapy (VMAT) technique has been shown to allow better dose conformation with low dose levels to organs at risk (OARs), compared to static fields three-dimensional Conformal Radiotherapy (3D-CRT). The aim of this study was to evaluate the feasibility and dosimetric advantages of sequential boost (SB), administered with VMAT tech-nique in hybrid plans with tangential beams for whole breast treatment. Material and methods: BC patients undergoing adjuvant RT from June to October 2020 were selected. ESTRO guidelines for the Clinical Target Volume (CTV) delineation were used. Total delivered dose was 60-66 Gy; 50 Gy in 2 Gy daily fractions for whole breast and 10-16 in 2 Gy daily fractions Gy to tumor bed was 10-16 Gy in 2 Gy daily fractions. Results: The analysis included 31 patients with BC treated with adjuvant RT following con-servative surgery. Hybrid treatment plans characterized by a 3D-CRT plan using tangential medi-olateral and lateromedial fields for the irradiation of the whole breast Planning Target Volume (PTV) and a sequential VMAT plan with 2 coplanar arches for boost PTV irradiation were gener-ated. Dosimetric analysis resulted in homogeneous target volumes coverage and OARs constraints compliance. As regarding to organs at risks (OARs), contralateral breast, ipsi- and contralateral lung and heart constraints values were analysed. Conclusions: In the frame BC RT, this dosimetric study showed that hybrid plans performed with 3D-CRT and VMAT techniques are feasible in terms of dosimetric outcomes. "

Publisher

Asociatia Societatea Transdisciplinara de Oncologie Personalizata Pentru Combaterea Cancerului - Stop Cancer

Reference40 articles.

1. "1. Gregucci F, Fozza A, Falivene S, Smaniotto D, Morra A, Daidone A, et al. Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group. Radiol Med (Torino) 2020;125:674-82. https://doi.org/10.1007/s11547-020-01147-5. 47. Piras A, Menna S, D'Aviero A, Marazzi F, Mazzini A, Cusumano D, Massaccesi M, Mattiucci GC, Daidone A, Valentini V, Boldrini L. New fractionations in breast cancer: a dosimetric study of 3D-CRT versus VMAT. https://doi.org/10.1002/jmrs.530

2. 2. Sedlmayer F, Sautter-Bihl M-L, Budach W, Dunst J, Fastner G, Feyer P, et al. DEGRO practical guidelines: radio-therapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al 2013;189:825-33. https://doi.org/10.1007/s00066-013-0437-8.

3. 3. Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, et al. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol 2018;8:145-52. https://doi.org/10.1016/j.prro.2018.01.012.

4. 4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet Lond Engl 2011;378:1707-16. https://doi.org/10.1016/S0140-6736(11)61629-2. 5. Valle LF, Agarwal S, Bickel KE, Herchek HA, Nalepinski DC, Kapadia NS. Hypofractionated whole breast radio-therapy in breast conservation for early-stage breast cancer: a systematic review and meta-analysis of randomized trials. Breast Cancer Res Treat 2017;162:409-17. https://doi.org/10.1007/s10549-017-4118-7.

5. 6. Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 2013;14:1086-94. https://doi.org/10.1016/S1470-2045(13)70386-3.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3